Colorectal Neoplasms: all 5,738 studies

Page 33 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.

• Immunotherapy for Third Line Metastatic Colorectal CancerCompletedNCT04444622Phase 2
• Cancer Communication Within Hispanic Social NetworksCompletedNCT04444232Not applicable
• Advanced Geriatric Evaluation and Quality of Life in Colorectal Cancer SurgeryCompletedNCT04443816
• Real World Study of Regorafenib Versus Fruquintinib in Colorectal CancerStatus unknownNCT04431791
• FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal CancerWithdrawnNCT04430985Phase 2
• Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyActive, not recruitingNCT04430725
• Does Delaying Curative Surgery for Colorectal Cancer Influence Long-term Disease Free Survival.CompletedNCT04430231
• Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal PolyposisActive, not recruitingNCT04430179Phase 2
• Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerActive, not recruitingNCT04428905Phase 3
• Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer PatientsCompletedNCT04425564Phase 2
• Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal CancerCompletedNCT04425239Phase 2
• Survival Analysis of Frail Patients With Localised Colorectal CancerCompletedNCT04422002
• Colorectal Cancer Immunomonitoring Combined With Radiofrequency ablatIonStatus unknownNCT04420013
• Cold EMR Vs Standard EMR for the Treatment of Large Nonpedunculated Homogeneous Colorectal LesionsCompletedNCT04418843Not applicable
• VOCs vs FIT for Colorectal Cancer ScreeningStatus unknownNCT04407416Not applicable
• Point of Care Faecal Immunochemical Testing for Colorectal CancerCompletedNCT04402424
• Effect of Hemp-CBD on Patients With CIPNStatus unknownNCT04398446Phase 2
• Longitudinal Incision Versus Cruciate Incision in the Construction of an End ColostomyStatus unknownNCT04397783Not applicable
• Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal CancerStatus unknownNCT04397601
• Effectiveness of Endocuff Vision in Improving ADRCompletedNCT04395352
• Identification of New Diagnostic Protein Markers for Colorectal CancerCompletedNCT04394572
• Patients' Guidance With Onco-Coaching and CANKADO on Systemic Chemotherapy for Metastatic Colorectal CancerCompletedNCT04393116
• TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.Active, not recruitingNCT04392479Phase 3
• A Community-Based Educational Intervention to Improve Colorectal Cancer ScreeningSuspendedNCT04392050
• Efficacy of a Mobile Clinical Decision Support System (CaPtyVa CCR App) to Improve Performance of Gastroenterology and Coloproctology Specialists in Colorectal Cancer Screening and Surveillance According to Guideline Recommendations: A Randomized Clinical Trial.Status unknownNCT04389502Not applicable
• Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid BiopsyStatus unknownNCT04385316
• A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal CancerStatus unknownNCT04380103Phase 1/2
• A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal CancerStatus unknownNCT04380012Phase 2
• Peristomal Skin Complications and Quality of LifeCompletedNCT04375930Not applicable
• To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer PatientsCompletedNCT04368507Phase 1/2
• Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal CancerCompletedNCT04362839Phase 1
• Breath Analysis as an Additional Test for Colorectal Cancer Screening to Reduce the Number of Unnecessary ColonoscopiesCompletedNCT04357158Not applicable
• Mu Opioid Receptor 1 Expression and Activation Patterns in Colorectal CancerStatus unknownNCT04353882
• Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsTerminatedNCT04348916Phase 1
• Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerWithdrawnNCT04348643Phase 1/2
• Telephone Services for Participation in Colorectal Cancer ScreeningStatus unknownNCT04348058Not applicable
• Effects of Fasting Strategies on Postoperative Recovery and Long-term Prognosis in Patients With Colorectal CancerStatus unknownNCT04345978Not applicable
• Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid TumorsCompletedNCT04344795Phase 1
• SMS Messaging as a Tool to Improve Cancer Screening ProgramsCompletedNCT04343950Not applicable
• A Retrospective Study Project of Clinico-molecular Characterization in Patients With Metastatic Colorectal CancerCompletedNCT04338542
• A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal CancerStatus unknownNCT04337879Phase 1/2
• A Retrospective Cohort Study Outcome of Treatment in Asymptomatic Stage 4 Colorectal CancerCompletedNCT04334395
• The Genomic Medicine at VA StudyActive, not recruitingNCT04331535Not applicable
• The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal CancerStatus unknownNCT04326296Phase 1
• A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal CancerStatus unknownNCT04324476Phase 2
• "High Levels of EMT-TFs for the Diagnosis of Colorectal Cancer (CRC)"Status unknownNCT04323813
• National Cancer Institute "Cancer Moonshot Biobank"Active, not recruitingNCT04314401
• Ultrasound-Guided Erector Spinae Plan Block for Colorectal SurgeryStatus unknownNCT04313764Not applicable
• The PRIME-CRC Trial to Promote CRC Screening in Rural CommunitiesActive, not recruitingNCT04313114Not applicable
• Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal CancerStatus unknownNCT04310176Phase 2
• Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal CancerActive, not recruitingNCT04304209Phase 2
• Colorectal Cancer Screening Using Stool DNA-based SDC2 Methylation TestCompletedNCT04304131Not applicable
• Analysis of Intestinal Microflora Combined With DNA Methylation in Stool to Detect Colorectal CancerStatus unknownNCT04302363
• PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal CancerActive, not recruitingNCT04301557Phase 2
• A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457）Status unknownNCT04298320Phase 1/2
• Two Low Volume Regimens for Colorectal Cancer Screening ColonoscopyCompletedNCT04297423Phase 4
• Niclosamide for Familial Adenomatous PolyposisStatus unknownNCT04296851Phase 2
• Efficacy of Perioperative Duloxetine as a Part of Multimodal Analgesia in Laparoscopic Colorectal Cancer SurgeryStatus unknownNCT04294953Phase 2
• TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon CancerActive, not recruitingNCT04294264Phase 2
• A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal CancerTerminatedNCT04294160Phase 1
• Screening of Colorectal Cancer in the Public Healthcare Sector in ArgentinaStatus unknownNCT04293315Not applicable
• Optimising Colorectal Cancer Screening ParticipationCompletedNCT04292366Not applicable
• Back-to-back Endoscopy Versus Single-pass Endoscopy and Chromoendoscopy in IBD SurveillanceCompletedNCT04291976Not applicable
• Emergency Curative Resection of Colorectal CancerCompletedNCT04288284
• Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in ChinaCompletedNCT04287335
• Reducing Fear of Cancer Recurrence in Danish Colorectal Cancer SurvivorsCompletedNCT04287218Not applicable
• Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal SurgeryActive, not recruitingNCT04281667Phase 4
• Next-generation Sequencing of Colorectal Cancer Somatic Cells to Guide Genetic Susceptibility Gene Mutations Screening.Status unknownNCT04280666
• Effectiveness and Safety of the Colonoscopy Assisted by Endocuff vs. Standard in the Colorectal Cancer ScreeningCompletedNCT04280393Not applicable
• A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid TumorsTerminatedNCT04278144Phase 1/2
• Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)CompletedNCT04271813Phase 2
• Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer PatientsStatus unknownNCT04269746
• Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal CancerStatus unknownNCT04268290Phase 2
• BESPOKE Study of ctDNA Guided Therapy in Colorectal CancerActive, not recruitingNCT04264702
• Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal CancerStatus unknownNCT04264676Phase 2
• Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal CancerActive, not recruitingNCT04262635Phase 3
• Pedaling at a Low-Moderate Intensity During Chemotherapy AdministrationWithdrawnNCT04258969Not applicable
• Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized StudyActive, not recruitingNCT04258137Not applicable
• IBI310 in Combination with Sintilimab in Patients with DNA Mismatch Repair Deficient (dMMR)/microsatellite Instability High (MSI-H) Locally-advanced or Metastatic Colorectal CancerTerminatedNCT04258111Phase 2
• The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.CompletedNCT04252560
• Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE StatusStatus unknownNCT04252456Not applicable
• Surgical Prehabilitation of Cancer Patients Undergoing Colorectal Resection.CompletedNCT04248647Not applicable
• A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal CancerCompletedNCT04247984Phase 2
• A Prospective Single-Center Evaluation of SureForm™ Staplers in Robotic-assisted Colorectal ProceduresCompletedNCT04247958
• A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRIStatus unknownNCT04247256Phase 1/2
• Tocotrienol and Bevacizumab in Metastatic Colorectal CancerActive, not recruitingNCT04245865Phase 2
• A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesTerminatedNCT04244552Phase 1
• 4-week Serial FIT Analysis in Patients With CRCCompletedNCT04242901
• A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal CancerStatus unknownNCT04241731Phase 2
• Primary Care Clinical Excellence Incentive StudyCompletedNCT04237883Not applicable
• Early Detection of Relapses in Stage IV Colorectal Cancer PatientsStatus unknownNCT04232891
• Change in Body Weight During Treatment of Advanced Colorectal CancerStatus unknownNCT04232748
• Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal CancerStatus unknownNCT04231175Not applicable
• Clinical Outcomes of NOSES Versus Traditional Robotic-assisted Surgery for Patients With Colorectal CancerStatus unknownNCT04230772Not applicable
• Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal CancerActive, not recruitingNCT04230187Phase 3
• The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal CancerStatus unknownNCT04230018
• Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRCStatus unknownNCT04229537Phase 1
• Evaluation of Somatic Mutation Spectrum as Biomarker for Survival Outcome in Chinese CRCStatus unknownNCT04228614
• Healthy Eating and Active Lifestyle After Bowel Cancer: HEAL ABCCompletedNCT04227353Not applicable
• A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal CancerStatus unknownNCT04227041Phase 1/2

← Colorectal Neoplasms overview